Reproductive Biotechnology Group

Research Leader: Associate Professor Mark Nottle

The Reproductive Biotechnology group has an international reputation in the general areas of reproductive biology and the development of associated technologies for biomedical and agricultural applications. In collaboration with a number of university, institute and hospital research groups in Australia as well as overseas, current research is focused on developing organ, tissue and cell replacement therapies.

This work is funded by various agencies including the Juvenile Diabetes Research Foundation, the National Health and Medical Research Council and industry.

In 2009 the group presented its findings regarding the development of a new method for the isolation of mammalian embryonic stem cells including its use in isolating embryonic stem cells from the pig.

Research Priorities:

• Isolation and characterisation of various stem cell types from the pig. These will be used for a range biomedical and agricultural applications, as well as a model for human stem cell research.